Simultaneous determination and pharmacokinetics study of four quinones in rat plasma by ultra high performance liquid chromatography with electrospray ionization tandem mass spectrometry after the oral administration of Qianzhi capsules. Issue 10 (12th March 2018)

• Record Type: Journal Article
• Authors: Gao, Mingjie; Wang, Zhibin; Yang, Jing; Wang, Liqian; Wu, Chengcui; Cui, Binbin; Yang, Chunjuan
• Is Part Of: Journal of separation science. Volume 41:Issue 10(2018)
• Page Start: 2161
• Page End: 2168
• Publication Date: 2018-03-12
• Subjects: pharmacokinetics -- Qianzhi capsules -- rat plasma -- traditional Chinese medicine -- ultra high performance liquid chromatography; Separation (Technology) -- Periodicals; Chromatographic analysis -- Periodicals; 543.089
• DOI: 10.1002/jssc.201700981
• Languages: English
• ISSNs: 1615-9306

Abstract

Abstract: A sensitive, specific, and accurate ultra high‐performance liquid chromatography with electrospray ionization tandem mass spectrometry method was developed and validated for the simultaneous quantification of purpurin, munjistin, mollugin, and alizarin from Qianzhi capsules in rat plasma. Chromatographic separation was performed on an Agilent Eclipse Plus C18 RRHD column with a mobile phase consisting of methanol and 5 mM ammonium acetate/water with gradient elution. The analytes were quantified on a triple quadrupole mass spectrometer, operating in the multiple reaction monitoring mode and switching the electrospray ion source polarity with positive electrospray ionization in a single run. Samples were pretreated by liquid–liquid extraction with cyclohexane. The intra‐ and interday precision and accuracy of the assay were within acceptable ranges. Matrix effects for all of the analytes were between 90.16 and 100.21%. The average recovery ranged from 75.38 to 88.96%. This method was successfully applied to study the pharmacokinetic parameters of the four compounds in rat plasma after oral administration of Qianzhi capsules. Four quinones could be rapidly absorbed into blood ( t max, 0.80–1.93 h) and eliminated relatively slowly ( t 1/2, 8.07–11.97 h). The results might be helpful for guiding the clinical application of Qianzhi capsules in the future.